Aktuelles

Watch out for the toxic mix!

Just how risky are the toxic compounds in genetically engineered plants?
Friday, 29 April 2011
Munich/Berlin

Testbiotech is warning that toxic compounds found in genetically engineered plants are increasingly burdening the food chain. Particular reasons for concern are raised about residues from herbicides and insecticides. Though it is known that the amount of residues in the plants is increasing, there are hardly any controls and risk assessment is insufficient. The report was commissioned by Ulrike Hoefken, a Green Member of the German Parliament.

Input to the EU Commission´s Consultation on Environmental Risk Assessment of Genetically Engineered Plants.

Testbiotech has thus far published two reports on the risk assessment of genetically engineered crops in the EU (Then&Potthof, 2009; Then, 2010) and prepared several background papers. Here we have drawn up a short overview of the most relevant points for consultation on the environmental risk assessment of genetically engineered plants.

Synthetische Biologie: Schavan führt Bundestag in die Irre

Irreführende Angaben zur staatlichen Förderung, Verharmlosung der Risiken
Wednesday, 6 April 2011
München/ Berlin

Das Bundesministerium für Bildung und Forschung macht irreführende Angaben zur finanziellen Förderung der Synthetischen Biologie. Auf eine Anfrage des Bundestagsabgeordneten Rene Röspel (SPD) antwortet das Ministerium von Annette Schavan (BT-Drs. 17/4898), dass es seit 2005 keine Forschungs- und Entwicklungsprojekte in diesem Bereich gefördert habe. Nach Recherchen von Testbiotech ist diese Aussage nicht korrekt.

EU about to approve genetically engineered maize with potential health risk

The European Union Agriculture Council will on March 17 2011 deal with a market application of a so called 'stacked event' for MON 89034 × MON 88017 maize (Monsanto). Another new application for cotton GHB614 (Bayer) is on the agenda as well as renewal of application for maize 1507 (Pioneer). Testbiotech urges these applications be rejected, because necessary standards for assessing health risks are not met and recent publications show the need for further investigations.

File attachments: 

Pages

Alle | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009